Pfizer Stock News

Pfizer plans to file for an expanded approval of Abrysvo, which is currently approved for adults ages 60 and above and expectant mothers.

The stock market's been wobbly in the past couple of weeks, influenced by Federal Reserve officials' cautious stance on cutting interest rates. However, with a cooling job market, it's only a matter o

Ken Griffin's Citadel hedge fund more than quadrupled its stake in this stock in 2023 Q4. Griffin probably likes the stock because of its valuation, dividend, and surprisingly robust growth prospects.

In the latest trading session, Pfizer (PFE) closed at $26.58, marking a -0.3% move from the previous day.

Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Pfizer has had plenty of bad news, with more on the way. New products and acquisitions should help the drugmaker return to growth.

One estimate suggests artificial intelligence (AI) can add close to $16 trillion to the global economy by the turn of the decade. Nvidia is rife with red flags, which may have been the catalyst that e

With the market off to a rather wobbly start to the second quarter of 2024, investors may be looking for the most undervalued biotech stocks to buy in April that can offer more bang for one's buck. Fo

The Investment Committee gives you their top stocks to watch for the second half.

I present you our framework for buying and selling dividend stocks. It follows our simple motto of buy low, sell high, get paid to wait. Here are 2 brilliant buys and 2 smart sells for Q2 2024.

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

Given its attractive valuation, we believe Pfizer stock (NYSE: PFE) is a better pick than its peer — Merck stock (NYSE: MRK). MRK trades at a higher valuation multiple of 5.6x revenues vs.

Blue Chip stocks are among the most dependable investments available. For that reason many investors believe them to be an unbeatable investment overall.

It's an interesting time in the market, which may bode well for conservative ideas found among blue-chip stocks. Underlying this category are some of the strongest, most established businesses and bra